rabbit
haemorrhag
diseas
viru
rhdv
singlestrand
positivesens
rna
viru
genu
lagoviru
famili
calicivirida
suscept
adult
european
rabbit
oryctolagu
cuniculu
viru
caus
rabbit
haemorrhag
diseas
rhd
fulmin
necrotis
hepat
case
fatal
rate
approxim
rhdv
highli
speciesspecif
environment
stabl
transmit
direct
contact
via
fomit
mechan
insect
factor
along
high
case
fatal
rate
rhd
prompt
investig
use
rhdv
biocontrol
agent
manag
australia
wild
rabbit
earli
rhdv
czech
strain
capm
belong
rhdv
genogroup
releas
australia
sinc
natur
outbreak
occur
regularli
wild
rabbit
popul
addit
ongo
releas
origin
capm
viru
howev
effect
origin
strain
limit
immun
recov
rabbit
emerg
genet
resist
popul
factor
impact
effect
biocontrol
rhdv
agedepend
resist
partial
crossprotect
afford
relat
benign
caliciviru
endem
southeastern
australia
recent
evid
shown
wild
rabbit
number
australia
recov
initi
knockdown
due
rhdv
facilit
longterm
sustain
rhdvmediat
rabbit
biocontrol
australia
necessari
identifi
rhdv
antigen
variant
abl
overcom
immun
capm
circul
field
strain
howev
even
caliciviru
strain
use
field
time
resist
immun
inevit
develop
rabbit
number
recov
would
therefor
highli
desir
pipelin
continu
gener
novel
viru
variant
deploy
ongo
fashion
endur
effect
biocontrol
robust
cell
cultur
reliabl
revers
genet
system
rhdv
establish
pipelin
must
present
involv
passag
select
virus
rabbit
report
develop
experiment
vivo
platform
direct
evolut
rhdv
variant
demonstr
proofofprincipl
method
may
use
gener
virus
alter
phenotyp
anim
trial
carri
csiro
black
mountain
laboratori
accord
australian
code
care
use
anim
scientif
purpos
approv
csiro
ecosystem
scienc
anim
ethic
committe
permit
identifi
cesaec
domrab
new
zealand
white
rabbit
week
old
hous
either
individu
pair
depend
size
rabbit
neg
antibodi
anim
infect
oral
ml
clarifi
liver
homogen
prepar
initi
wild
rabbit
die
infect
highli
virul
field
strain
subsequ
liver
singl
anim
preced
passag
homogen
dilut
pb
contain
rhdv
capsid
gene
copi
inoculum
determin
qrtpcr
describ
monitor
conduct
twice
daili
hour
rabbit
anaesthetis
intramuscular
inject
either
zoletil
virbac
peakhurst
nsw
australia
combin
troy
laboratori
smithfield
nsw
australia
ketamav
mavlab
logan
qld
australia
rhdvspecif
mous
monoclon
antibodi
mab
dilut
steril
pb
administ
intraven
mab
rais
rhdv
laboratori
refer
strain
genbank
access
purifi
puriti
use
protein
chromatographi
describ
previous
antibodi
quantifi
assum
one
mgml
differ
dose
mab
administ
rabbit
within
passag
dose
rang
increas
subsequ
passag
fig
addit
intraven
administr
antibodi
rabbit
passag
given
subsequ
daili
dose
mab
intramuscularli
maintain
select
pressur
rabbit
euthanis
either
three
four
day
postinfect
prior
induct
strong
detect
igm
respons
human
endpoint
reach
whichev
earlier
human
endpoint
experi
defin
acut
weight
loss
clinic
sign
consist
termin
rhd
ie
normo
hypothermia
pyrexia
combin
weight
loss
alter
mentat
andor
anorexia
euthanasia
perform
intraven
intracardiac
inject
sodium
pentobarbiton
virbac
induc
gener
anaesthesia
either
zoletil
intramuscularli
combin
ketamav
intramuscularli
effort
made
minimis
suffer
throughout
experiment
process
eg
interven
anim
fulmin
rhd
anaesthetis
anim
prior
intraven
inject
includ
euthanasia
unexpect
death
occur
experi
howev
must
note
rhd
frequent
peracut
infect
anim
may
die
suddenli
expect
consequ
infect
tissu
sampl
includ
blood
bile
liver
collect
postmortem
store
process
liver
one
anim
per
passag
use
prepar
inoculum
subsequ
passag
ten
serial
passag
complet
fig
nine
addit
rabbit
one
per
passag
passag
use
unselect
control
monitor
background
mutat
rate
infect
origin
inoculum
viru
trial
conduct
describ
without
antibodi
administr
liver
prepar
control
rabbit
passag
use
gener
inoculum
control
anim
subsequ
passag
highli
virul
australian
rhdv
field
isol
genbank
access
use
stock
viru
product
strain
select
order
gener
genogroup
antigen
variant
base
circul
australian
field
strain
produc
inoculum
viru
stock
singl
adult
new
zealand
white
rabbit
infect
subcutan
inject
liver
homogen
prepar
wild
rabbit
die
infect
expect
laboratori
rabbit
die
three
day
postinfect
liver
harvest
tissu
homogen
prepar
pb
homogen
clarifi
twice
centrifug
minut
g
allegra
follow
minut
g
beckmann
avanti
filter
syring
filter
millex
bayswat
vic
australia
follow
syring
filter
millex
store
viru
concentr
capsid
gene
copi
per
determin
qrtpcr
use
rhdvspecif
forward
fw
revers
rv
primer
describ
rna
isol
mg
liver
use
qiagen
rneasi
mini
kit
qiagen
chadston
vic
australia
accord
manufactur
instruct
homogenis
glass
bead
daintre
scientif
st
helen
ta
australia
use
precelli
tissu
homogenis
bertin
technolog
montignylebretonneux
franc
viral
load
quantifi
capsid
gene
copi
number
unit
use
qrtpcr
method
essenti
describ
previous
reaction
perform
duplic
use
sensifast
sybr
norox
onestep
kit
biolin
alexandra
nsw
australia
biorad
thermal
cycler
platform
use
primer
firststrand
cdna
synthesis
rna
use
ng
oligodt
genework
thebarton
sa
australia
invitrogen
superscript
iii
life
technolog
mulgrav
vic
australia
accord
manufactur
direct
overlap
fragment
rhdv
genom
amplifi
pcr
use
platinum
taq
dna
polymeras
high
fidel
life
technolog
use
primer
set
fw
rv
gccatrgtygcaagrttgac
fw
rv
catcat
fw
rv
rhdvend
rv
necessari
rv
fragment
split
two
fragment
amplifi
separ
primer
pair
rv
fw
rv
similarli
rv
fragment
split
two
fragment
amplifi
primer
pair
rv
fw
rv
requir
viru
genom
could
amplifi
singl
fragment
use
primer
pair
rv
amplicon
viru
ie
individu
anim
quantifi
use
qubit
dsdna
br
assay
life
technolog
pool
equimolar
ratio
dilut
final
concentr
ultrapur
dnasernasefre
distil
water
life
technolog
sequenc
data
analysi
perform
describ
previous
modif
dna
librari
prepar
ng
pool
amplicon
use
nextera
xt
dna
sampl
prepar
kit
illumina
scoresbi
vic
australia
accord
manufactur
direct
pairedend
sequenc
perform
use
illumina
miseq
platform
cycl
miseq
reagent
kit
raw
sequenc
read
upload
ncbi
sequenc
read
archiv
access
number
sequenc
read
qualiti
assess
use
fastqc
http
wwwbioinformaticsbabrahamacukprojectsfastqc
read
trim
use
trimmomat
read
nucleotid
nt
start
one
nt
end
remov
slide
window
four
nt
appli
averag
qualiti
score
threshold
set
overlap
pairedend
read
merg
flash
read
less
nt
length
discard
individu
clean
read
origin
inoculum
viru
sequenc
map
genom
genbank
access
gener
major
consensu
sequenc
use
geneiou
read
subsequ
isol
map
origin
inoculum
consensu
sequenc
sequenc
label
passag
number
p
anim
number
k
eg
polymorph
analysi
individu
clean
read
map
major
consensu
sequenc
respect
isol
averag
sequenc
coverag
approxim
nucleotid
polymorph
present
detect
use
find
variationssnp
tool
avail
geneiou
call
base
differ
origin
inoculum
viru
consensu
sequenc
sequenc
polymorph
defin
nucleotid
polymorph
exceed
isol
viru
popul
correspond
consensu
sequenc
chang
respect
isol
amino
acid
variat
detect
sequenc
analysi
map
protein
structur
biolog
assembl
rhdv
pbd
access
p
domain
pdb
access
use
protein
structur
viewer
implement
geneiou
itass
onlin
server
http
zhanglabccmbmedumicheduitass
use
predict
threedimension
protein
structur
base
amino
acid
sequenc
antigen
profil
rhdv
refer
strain
genbank
access
antigen
variant
rhdva
refer
strain
genbank
access
passag
viru
share
amino
acid
ident
parent
viru
variant
deriv
serial
passag
studi
compar
use
panel
seven
lagovirusspecif
mab
sandwich
elisa
method
previous
describ
briefli
liver
homogen
pretitr
use
dilut
gave
valu
closest
liver
homogen
preincub
mab
satur
dose
mab
minut
antigenantibodi
mixtur
distribut
elisa
plate
previous
coat
overnight
hyperimmun
rhdv
serum
dilut
standard
carbon
buffer
incub
hour
plate
wash
incub
mixtur
mab
hour
final
horseradish
peroxidaselabel
rabbit
antimous
igg
use
detect
bind
mab
viru
viru
valu
obtain
nonbind
mab
neg
control
set
inhibit
rhdv
use
refer
strain
mab
antigen
variant
rhdva
refer
strain
mab
respect
reactiv
set
inhibit
percent
inhibit
mab
toward
viru
calcul
valu
viru
test
x
minu
valu
refer
strain
ref
divid
valu
viru
test
mab
neg
minu
valu
refer
strain
ie
initi
ie
passag
select
rhdv
viru
perform
use
rel
low
mab
concentr
fig
although
viru
replic
high
titr
low
mab
dose
higher
antibodi
dose
restrict
replic
less
capsid
gene
copi
per
mg
liver
passag
compar
capsid
gene
copi
per
mg
liver
control
anim
interestingli
passag
highlevel
replic
observ
antibodi
dose
test
rang
fig
suggest
partial
immun
escap
occur
passag
passag
viru
abl
replic
presenc
previous
inhibitori
antibodi
concentr
passag
viru
replic
high
level
presenc
mab
concentr
anim
fig
howev
high
dose
mab
ie
administ
concurr
infect
passag
rather
hour
postinfect
viru
replic
suppress
demonstr
viru
complet
escap
antibodi
bind
fig
may
limit
use
newli
gener
viru
biocontrol
agent
wild
immun
preexist
rather
induc
addit
experi
natur
immun
rabbit
requir
address
issu
specul
initi
period
postinfect
virus
passag
onward
abl
reach
titr
high
enough
overcom
mab
neutralis
suggest
viru
may
respond
select
pressur
acceler
replic
speed
rather
via
immun
escap
importantli
howev
newli
gener
viru
passag
still
highli
virul
passag
experi
caus
termin
rhd
within
day
postinfect
intrahost
heterogen
major
consensu
sequenc
viru
popul
within
isol
explor
full
genom
sequenc
nucleotid
polymorph
present
intrahost
viru
popul
determin
order
monitor
chang
serial
passag
fig
two
consensu
nucleotid
polymorph
code
mutat
detect
first
passag
posit
second
passag
posit
fig
substitut
rapidli
becam
domin
fix
viru
popul
neither
mutat
observ
control
anim
viru
popul
fig
emerg
mutat
correl
abil
viru
overcom
increas
antibodi
dose
fig
suggest
amino
acid
chang
affect
bind
mab
rhdv
virion
compos
unit
capsid
protein
subdivid
intern
shell
expos
protrus
p
domain
p
domain
divid
subdomain
extern
locat
two
amino
acid
mutat
appear
passag
locat
domain
within
previous
describ
hypervari
e
c
surfac
region
chang
map
p
domain
rhdv
juxtapos
suggest
site
may
involv
format
conform
epitop
mab
bind
fig
two
site
separ
nm
singl
monom
impli
amino
acid
chang
inde
occur
within
epitop
threedimension
structur
predict
use
itass
server
show
evid
major
topolog
rearrang
due
two
amino
acid
chang
combin
observ
infect
newli
gener
viru
suggest
receptor
bind
affect
data
shown
posit
locat
within
promin
loop
region
aa
expos
divers
region
virion
surfac
adjac
three
put
histoblood
group
antigen
bind
pocket
variat
site
previous
report
rhdv
capm
describ
primari
determin
virushost
interact
also
major
immunodomin
epitop
shown
peptid
gener
region
stimul
product
neutralis
antibodi
homolog
posit
murin
also
known
antibodi
bind
site
posit
lie
either
adjac
variabl
loop
region
second
three
surfac
loop
howev
exact
posit
region
well
defin
loop
inher
flexibl
therefor
poorli
structur
defin
may
thu
readili
accommod
structur
chang
inde
chang
loop
suggest
defin
antigen
caliciviru
virion
therefor
surpris
observ
chang
respons
immun
select
occur
region
howev
contrast
studi
identifi
singl
amino
acid
chang
capabl
complet
abrog
antibodi
neutralis
includ
calicivirus
two
amino
acid
chang
posit
mediat
partial
escap
mab
vivo
detect
chang
mab
bind
vitro
antigen
characteris
sandwich
elisa
show
chang
percent
inhibit
serial
passag
mab
use
select
mab
fig
howev
reduc
reactiv
compar
parent
viru
detect
mab
ie
mab
lesser
extent
fig
interestingli
increas
reactiv
observ
mab
crossreact
strongli
antigen
variant
rhdva
virus
classic
rhdv
virus
fig
taken
togeth
data
confirm
passag
viru
antigen
distinct
parent
viru
overal
antigen
reactiv
profil
passag
viru
evolv
toward
rhdva
phenotyp
although
observ
amino
acid
chang
affect
mab
bind
mutat
caus
chang
capsid
conform
clearli
affect
bind
mab
epitop
map
publish
found
epitop
mab
uniqu
l
capucci
unpublish
data
unknown
amino
acid
chang
select
observ
mutat
affect
mab
bind
conceiv
chang
affect
vivo
bind
mab
way
detect
sandwich
elisa
altern
chang
could
affect
immun
function
complement
bind
opsonis
addit
two
code
mutat
identifi
strong
evid
select
synonym
c
mutat
nucleotid
posit
within
rnadepend
rna
polymeras
code
region
amino
acid
polymeras
affect
codon
alanin
fig
mutat
first
detect
passag
rapidli
becam
fix
subsequ
passag
mutat
observ
unselect
passag
fig
impact
mutat
fit
rhdv
present
unclear
previous
report
silent
mutat
select
enhanc
viral
fit
variou
mechan
exampl
codon
usag
bia
improv
genet
stabil
via
alter
rna
secondari
higherord
structur
lastli
equal
conceiv
silent
mutat
simpli
passeng
mutat
aris
genet
drift
futur
experi
may
reveal
whether
similar
mutat
aris
similar
select
pressur
addit
three
polymorph
discuss
number
genet
chang
synonym
code
detect
viru
popul
low
level
becom
fix
presum
neutral
deleteri
effect
viral
fit
select
serial
passag
interestingli
mutat
nucleotid
posit
within
code
region
consist
present
rel
low
frequenc
anim
without
antibodi
treatment
except
two
passag
fig
biolog
signific
polymorph
remain
determin
overal
averag
number
polymorph
appear
per
passag
compar
select
control
group
data
shown
suggest
immun
pressur
stimul
stressinduc
mutagenesi
phenomenon
wide
describ
bacteria
eukaryot
archaea
review
howev
number
polymorph
clearli
increas
later
passag
compar
earlier
passag
select
control
rabbit
fig
may
due
adapt
viru
laboratori
rabbit
sinc
origin
inoculum
viru
isol
wild
rabbit
importantli
evid
attenu
rhdv
serial
passag
vivo
passag
viru
highli
virul
passag
experi
caus
clinic
rhd
within
hour
postinfect
onset
termin
sign
day
postinfect
essenc
studi
experi
adapt
evolut
monitor
genet
dynam
viru
popul
serial
transfer
neutral
mutat
gener
take
long
timescal
reach
fixat
popul
benefici
mutat
often
undergo
select
sweep
rapidli
reach
fixat
review
support
observ
two
amino
acid
chang
identifi
capsid
region
along
silent
substitut
viral
polymeras
benefici
antibodi
select
fig
contrast
none
mutat
observ
unselect
popul
reach
fixat
cours
experi
despit
initi
fit
increas
passag
continu
passag
produc
complet
immun
escap
variant
observ
consist
idea
diminish
return
epistasi
rate
fit
increas
diminish
time
shape
logarithm
function
pattern
fit
chang
commonli
seen
laboratoryevolv
popul
process
optimis
fit
gradual
accumul
benefici
mutat
contrast
allornon
epistasi
keyston
mutat
occur
background
neutral
potenti
mutat
lead
sudden
chang
phenotyp
innov
weaker
select
like
lead
gradual
fit
increas
sinc
altern
pathway
avail
optimis
howev
keyston
mutat
abl
overcom
extrem
select
pressur
may
favour
landscap
weaker
select
pressur
may
thu
outcompet
less
benefici
mutat
clonal
interfer
altern
strong
select
pressur
may
favour
rare
extrem
innov
mutat
may
prevent
accumul
essenti
potenti
mutat
innov
mutat
may
also
lead
local
peak
fit
landscap
make
altern
evolutionari
pathway
inaccess
may
case
either
two
capsid
protein
chang
observ
studi
chang
could
driven
viru
evolutionari
culdesac
therebi
prevent
fit
optimis
find
demonstr
proofofprincipl
rhdv
evolut
experiment
manipul
select
viru
variant
alter
biolog
characterist
observ
two
amino
acid
substitut
within
domain
capsid
protein
rapidli
becam
fix
viru
popul
mab
select
addit
observ
select
synonym
substitut
within
polymeras
sinc
high
concentr
mab
continu
inhibit
variant
viru
given
concurr
infect
mechan
antigen
variat
may
account
fit
advantag
confer
mutat
exampl
mutant
may
acceler
replic
cycl
rapid
cell
entri
taken
togeth
develop
vivo
platform
select
novel
rhdv
variant
may
ultim
lead
target
evolut
viru
strain
replac
current
rabbit
biocontrol
agent
